Exact Mass: 662.5848937999999
Exact Mass Matches: 662.5848937999999
Found 393 metabolites which its exact mass value is equals to given mass value 662.5848937999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
CE(DiMe(9,3))
CE(DiMe(9,3)) is a cholesterol fatty acid ester or simply a cholesterol ester (CE). Cholesterol esters are cholesterol molecules with long-chain fatty acids linked to the hydroxyl group. They are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesterol esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesterol esters tend to contain relatively high proportions of C18 fatty acids. Cholesterol esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesterol esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesterol esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesterol esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesterol esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesterol esters from CoA esters of fatty acids and cholesterol. Cholesterol ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells.
Campesteryl linoleate
Constituent of corn oil and soybean oil. Campesteryl linoleate is found in cereals and cereal products, fats and oils, and pulses. Campesteryl linoleate is found in cereals and cereal products. Campesteryl linoleate is a constituent of corn oil and soybean oil
DG(20:0/0:0/18:2n6)
DG(20:0/0:0/18:2n6) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(20:0/0:0/18:2n6), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of linoleic acid at the C-3 position. The arachidic acid moiety is derived from peanut oil, while the linoleic acid moiety is derived from seed oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.
CE(7F7)
CE(7F7) is a furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(7F7) refers to the furan fatty acids 7-carbon carboxyalkyl moiety, the non-methylated furan moiety, and its 7-carbon alkyl moiety.
CE(8F6)
CE(8F6) is a furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(8F6) refers to the furan fatty acids 8-carbon carboxyalkyl moiety, the non-methylated furan moiety, and its 6-carbon alkyl moiety.
CE(9F5)
CE(9F5) is a furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(9F5) refers to the furan fatty acids 9-carbon carboxyalkyl moiety, the non-methylated furan moiety, and its 5-carbon alkyl moiety.
CE(9M4)
CE(9M4) is a furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(9M4) refers to the furan fatty acids 9-carbon carboxyalkyl moiety, the methyl substitution in the 3-position of its furan moiety, and its 4-carbon alkyl moiety.
CE(18:2(10E,12Z)+=O(9))
CE(18:2(10E,12Z)+=O(9)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(18:2(10E,12Z)+=O(9)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.
CE(18:2(9Z,11E)+=O(13))
CE(18:2(9Z,11E)+=O(13)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(18:2(9Z,11E)+=O(13)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.
CE(18:3(10,12,15)-OH(9))
CE(18:3(10,12,15)-OH(9)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(18:3(10,12,15)-OH(9)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.
CE(18:3(9,11,15)-OH(13))
CE(18:3(9,11,15)-OH(13)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(18:3(9,11,15)-OH(13)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.
DG(18:0/20:3(6,8,11)-OH(5)/0:0)
DG(18:0/20:3(6,8,11)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:0/20:3(6,8,11)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(6,8,11)-OH(5)/18:0/0:0)
DG(20:3(6,8,11)-OH(5)/18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(6,8,11)-OH(5)/18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:0/0:0/20:3(6,8,11)-OH(5))
DG(18:0/0:0/20:3(6,8,11)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(6,8,11)-OH(5)/0:0/18:0)
DG(20:3(6,8,11)-OH(5)/0:0/18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/18:2(10E,12Z)+=O(9)/0:0)
DG(20:0/18:2(10E,12Z)+=O(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/18:2(10E,12Z)+=O(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:2(10E,12Z)+=O(9)/20:0/0:0)
DG(18:2(10E,12Z)+=O(9)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(10E,12Z)+=O(9)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/18:2(10E,12Z)+=O(9))
DG(20:0/0:0/18:2(10E,12Z)+=O(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:2(10E,12Z)+=O(9)/0:0/20:0)
DG(18:2(10E,12Z)+=O(9)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/18:2(9Z,11E)+=O(13)/0:0)
DG(20:0/18:2(9Z,11E)+=O(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/18:2(9Z,11E)+=O(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:2(9Z,11E)+=O(13)/20:0/0:0)
DG(18:2(9Z,11E)+=O(13)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(9Z,11E)+=O(13)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/18:2(9Z,11E)+=O(13))
DG(20:0/0:0/18:2(9Z,11E)+=O(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:2(9Z,11E)+=O(13)/0:0/20:0)
DG(18:2(9Z,11E)+=O(13)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/18:3(10,12,15)-OH(9)/0:0)
DG(20:0/18:3(10,12,15)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/18:3(10,12,15)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:3(10,12,15)-OH(9)/20:0/0:0)
DG(18:3(10,12,15)-OH(9)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(10,12,15)-OH(9)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/18:3(10,12,15)-OH(9))
DG(20:0/0:0/18:3(10,12,15)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:3(10,12,15)-OH(9)/0:0/20:0)
DG(18:3(10,12,15)-OH(9)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/18:3(9,11,15)-OH(13)/0:0)
DG(20:0/18:3(9,11,15)-OH(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/18:3(9,11,15)-OH(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:3(9,11,15)-OH(13)/20:0/0:0)
DG(18:3(9,11,15)-OH(13)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(9,11,15)-OH(13)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/18:3(9,11,15)-OH(13))
DG(20:0/0:0/18:3(9,11,15)-OH(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:3(9,11,15)-OH(13)/0:0/20:0)
DG(18:3(9,11,15)-OH(13)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-18:0/20:3(6,8,11)-OH(5)/0:0)
DG(i-18:0/20:3(6,8,11)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-18:0/20:3(6,8,11)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(6,8,11)-OH(5)/i-18:0/0:0)
DG(20:3(6,8,11)-OH(5)/i-18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(6,8,11)-OH(5)/i-18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-18:0/0:0/20:3(6,8,11)-OH(5))
DG(i-18:0/0:0/20:3(6,8,11)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(6,8,11)-OH(5)/0:0/i-18:0)
DG(20:3(6,8,11)-OH(5)/0:0/i-18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/18:2(10E,12Z)+=O(9)/0:0)
DG(i-20:0/18:2(10E,12Z)+=O(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/18:2(10E,12Z)+=O(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:2(10E,12Z)+=O(9)/i-20:0/0:0)
DG(18:2(10E,12Z)+=O(9)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(10E,12Z)+=O(9)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/18:2(10E,12Z)+=O(9))
DG(i-20:0/0:0/18:2(10E,12Z)+=O(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:2(10E,12Z)+=O(9)/0:0/i-20:0)
DG(18:2(10E,12Z)+=O(9)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/18:2(9Z,11E)+=O(13)/0:0)
DG(i-20:0/18:2(9Z,11E)+=O(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/18:2(9Z,11E)+=O(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:2(9Z,11E)+=O(13)/i-20:0/0:0)
DG(18:2(9Z,11E)+=O(13)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(9Z,11E)+=O(13)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/18:2(9Z,11E)+=O(13))
DG(i-20:0/0:0/18:2(9Z,11E)+=O(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:2(9Z,11E)+=O(13)/0:0/i-20:0)
DG(18:2(9Z,11E)+=O(13)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/18:3(10,12,15)-OH(9)/0:0)
DG(i-20:0/18:3(10,12,15)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/18:3(10,12,15)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:3(10,12,15)-OH(9)/i-20:0/0:0)
DG(18:3(10,12,15)-OH(9)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(10,12,15)-OH(9)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/18:3(10,12,15)-OH(9))
DG(i-20:0/0:0/18:3(10,12,15)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:3(10,12,15)-OH(9)/0:0/i-20:0)
DG(18:3(10,12,15)-OH(9)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/18:3(9,11,15)-OH(13)/0:0)
DG(i-20:0/18:3(9,11,15)-OH(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/18:3(9,11,15)-OH(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:3(9,11,15)-OH(13)/i-20:0/0:0)
DG(18:3(9,11,15)-OH(13)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(9,11,15)-OH(13)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/18:3(9,11,15)-OH(13))
DG(i-20:0/0:0/18:3(9,11,15)-OH(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:3(9,11,15)-OH(13)/0:0/i-20:0)
DG(18:3(9,11,15)-OH(13)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
caffeoyl hexose
9(11),12-dien-urs-3beta-yl palmitate|9(11),12-ursadien-3beta-ol 3-O-palmitate|9(11),12-Ursadien-3??-ol 3-O-palmitate
2-trans,trans-Sorbo-1,3-dipalmitin|Glyceride-1,3-dipalmito-2-sorbate
(3beta)-olean-12-en-3-yl (9Z)-hexadec-9-enoate|3-O-[(9Z)-hexadec-9-enoyl]-beta-amyrin
3beta-linoleyloxyergost-7-ene|ergost-7-en-3beta-yl linoleate
Campesteryl linoleate
2-ethyl-2-(hydroxymethyl)-1,3-propanediyl dioleate
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
[(2S)-1-hydroxy-3-octadecanoyloxypropan-2-yl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2S)-3-hydroxy-2-octadecanoyloxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2R)-2-hydroxy-3-octadecanoyloxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2S)-2-hydroxy-3-octadecanoyloxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2S)-3-hydroxy-2-[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxypropyl] icosanoate
[(2S)-1-hydroxy-3-[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxypropan-2-yl] icosanoate
[(2R)-2-hydroxy-3-[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxypropyl] icosanoate
[(2S)-2-hydroxy-3-[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxypropyl] icosanoate
[(2S)-3-hydroxy-2-[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]oxypropyl] icosanoate
[(2S)-1-hydroxy-3-[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]oxypropan-2-yl] icosanoate
[(2R)-2-hydroxy-3-[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]oxypropyl] icosanoate
[(2S)-2-hydroxy-3-[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]oxypropyl] icosanoate
2-azaniumylethyl (2S,3R)-3-hydroxy-2-(palmitoylamino)octadecyl phosphate
C36H75N2O6P (662.5362459999999)
N-hexadecanoylsphinganine-1-phosphoethanolamine
C36H75N2O6P (662.5362459999999)
[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9Z,12Z)-nonadeca-9,12-dienoate
(1-dodecoxy-3-hydroxypropan-2-yl) (17Z,20Z)-octacosa-17,20-dienoate
[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] icosanoate
(2-Acetamido-3-hydroxynonacosyl) 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[1-hydroxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-henicos-11-enoate
[2-(Hexanoylamino)-3-hydroxypentacosyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[1-hydroxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-docos-13-enoate
(1-henicosoxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
[2-(Butanoylamino)-3-hydroxyheptacosyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[2-(Heptanoylamino)-3-hydroxytetracosyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[3-Hydroxy-2-(nonanoylamino)docosyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[1-hydroxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (Z)-icos-11-enoate
[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] docosanoate
[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] tetradecanoate
[1-hydroxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] dodecanoate
(1-hydroxy-3-tricosoxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(1-hydroxy-3-nonadecoxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
[3-Hydroxy-2-(octanoylamino)tricosyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[3-Hydroxy-2-(propanoylamino)octacosyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[1-[(Z)-henicos-11-enoxy]-3-hydroxypropan-2-yl] (Z)-nonadec-9-enoate
(1-hexadecoxy-3-hydroxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate
(1-hydroxy-3-octadecoxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate
(1-docosoxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
(1-hydroxy-3-tetradecoxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate
[2-(Docosanoylamino)-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[1-[(Z)-docos-13-enoxy]-3-hydroxypropan-2-yl] (Z)-octadec-9-enoate
[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] nonadecanoate
[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] tetracosanoate
[3-Hydroxy-2-(pentanoylamino)hexacosyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-hexacos-15-enoate
[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] octadecanoate
[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] (Z)-tetracos-13-enoate
[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] henicosanoate
[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] hexadecanoate
[1-hydroxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] (Z)-hexadec-9-enoate
(1-hydroxy-3-tetracosoxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] tricosanoate
(1-hydroxy-3-icosoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
[1-[(Z)-hexacos-15-enoxy]-3-hydroxypropan-2-yl] (Z)-tetradec-9-enoate
[2-(Decanoylamino)-3-hydroxyhenicosyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[2-(Henicosanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[3-Hydroxy-2-(nonadecanoylamino)dodecyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[3-Hydroxy-2-(icosanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[3-Hydroxy-2-(octadecanoylamino)tridecyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[3-Hydroxy-2-(undecanoylamino)icosyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (11E,14E)-heptadeca-11,14-dienoate
[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-octadec-11-enoate
(1-hydroxy-3-undecanoyloxypropan-2-yl) (17Z,20Z)-octacosa-17,20-dienoate
[17-(5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (10E,12E)-octadeca-10,12-dienoate
[17-[(E)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-heptadec-7-enoate
(2-nonanoyloxy-3-octanoyloxypropyl) (11Z,14Z)-henicosa-11,14-dienoate
2,3-di(octanoyloxy)propyl (13Z,16Z)-docosa-13,16-dienoate
2,3-di(nonanoyloxy)propyl (11Z,14Z)-icosa-11,14-dienoate
(2-dodecanoyloxy-3-octanoyloxypropyl) (9Z,12Z)-octadeca-9,12-dienoate
(3-octanoyloxy-2-tridecanoyloxypropyl) (9Z,12Z)-heptadeca-9,12-dienoate
(2-dodecanoyloxy-3-nonanoyloxypropyl) (9Z,12Z)-heptadeca-9,12-dienoate
(3-octanoyloxy-2-tetradecanoyloxypropyl) (9Z,12Z)-hexadeca-9,12-dienoate
(2-decanoyloxy-3-nonanoyloxypropyl) (9Z,12Z)-nonadeca-9,12-dienoate
(3-octanoyloxy-2-undecanoyloxypropyl) (9Z,12Z)-nonadeca-9,12-dienoate
(3-nonanoyloxy-2-tridecanoyloxypropyl) (9Z,12Z)-hexadeca-9,12-dienoate
[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-hexadec-9-enoate
(2-decanoyloxy-3-octanoyloxypropyl) (11Z,14Z)-icosa-11,14-dienoate
[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-hexadec-9-enoate
[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-heptadec-9-enoate
[3-octanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-pentadec-9-enoate
[3-nonanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-pentadec-9-enoate
(3-nonanoyloxy-2-undecanoyloxypropyl) (9Z,12Z)-octadeca-9,12-dienoate
[3-dodecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tridec-9-enoate
2,3-di(undecanoyloxy)propyl (9Z,12Z)-hexadeca-9,12-dienoate
[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate
(3-decanoyloxy-2-undecanoyloxypropyl) (9Z,12Z)-heptadeca-9,12-dienoate
(3-decanoyloxy-2-dodecanoyloxypropyl) (9Z,12Z)-hexadeca-9,12-dienoate
[3-decanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-pentadec-9-enoate
2,3-di(decanoyloxy)propyl (9Z,12Z)-octadeca-9,12-dienoate
[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-tetradec-9-enoate
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-hexacos-15-enoate
[3-Hydroxy-2-(tricosanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[3-Hydroxy-2-(tridecanoylamino)octadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[2-(Heptadecanoylamino)-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[2-(Hexadecanoylamino)-3-hydroxypentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[3-Hydroxy-2-(pentadecanoylamino)hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[3-Hydroxy-2-(tetradecanoylamino)heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[2-(Dodecanoylamino)-3-hydroxynonadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[3-hydroxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] icosanoate
[1-hydroxy-3-[(Z)-nonadec-9-enoyl]oxypropan-2-yl] (Z)-icos-11-enoate
(1-heptadecanoyloxy-3-hydroxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate
[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (Z)-tetracos-13-enoate
(1-hydroxy-3-tridecanoyloxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate
[1-hydroxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] (Z)-henicos-11-enoate
(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate
(1-hydroxy-3-octadecanoyloxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
(1-hydroxy-3-nonadecanoyloxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hydroxypropyl] tricosanoate
[1-[(Z)-heptadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (Z)-docos-13-enoate
[3-hydroxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] henicosanoate
[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] docosanoate
[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-hexacos-15-enoate
[3-dodecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (Z)-tridec-8-enoate
[3-dodecanoyloxy-2-[(Z)-dodec-5-enoyl]oxypropyl] (Z)-tetradec-9-enoate
[1-[(Z)-dodec-5-enoyl]oxy-3-[(Z)-tridec-8-enoyl]oxypropan-2-yl] tridecanoate
[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-dodecanoyloxypropyl] tetradecanoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-tridecanoyloxypropyl] tridecanoate
2,3-di(dodecanoyloxy)propyl (7Z,9Z)-tetradeca-7,9-dienoate
2,3-bis[[(Z)-dodec-5-enoyl]oxy]propyl tetradecanoate
(1-hydroxy-3-nonanoyloxypropan-2-yl) (19Z,22Z)-triaconta-19,22-dienoate
N-(pentadecanoyl)-hexadecasphinganine-1-phosphocholine
C36H75N2O6P (662.5362459999999)
N-(tetradecanoyl)-heptadecasphinganine-1-phosphocholine
C36H75N2O6P (662.5362459999999)
N-(heptadecanoyl)-tetradecasphinganine-1-phosphocholine
C36H75N2O6P (662.5362459999999)
N-(hexadecanoyl)-pentadecasphinganine-1-phosphocholine
C36H75N2O6P (662.5362459999999)
N-(dodecanoyl)-nonadecasphinganine-1-phosphocholine
C36H75N2O6P (662.5362459999999)
[(2S)-1-hydroxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (E)-tetracos-15-enoate
[(2S)-3-hydroxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (E)-tetracos-15-enoate
[(2S)-2-[(E)-heptadec-9-enoyl]oxy-3-hydroxypropyl] (E)-docos-13-enoate
[(2S)-3-hydroxy-2-tridecanoyloxypropyl] (5E,9E)-hexacosa-5,9-dienoate
[(2S)-1-heptadecanoyloxy-3-hydroxypropan-2-yl] (13E,16E)-docosa-13,16-dienoate
[(2R,3S)-2-(decanoylamino)-3-hydroxyhenicosyl] 2-(trimethylazaniumyl)ethyl phosphate
C36H75N2O6P (662.5362459999999)
[(2S)-3-hydroxy-2-nonadecanoyloxypropyl] (11E,14E)-icosa-11,14-dienoate
[(2S)-1-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] docosanoate
[(2S)-1-hydroxy-3-nonadecanoyloxypropan-2-yl] (11E,14E)-icosa-11,14-dienoate
[(2S)-1-hydroxy-3-tridecanoyloxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate
[(2S)-2-heptadecanoyloxy-3-hydroxypropyl] (13E,16E)-docosa-13,16-dienoate
[(2S)-1-hydroxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropan-2-yl] henicosanoate
[(2S)-1-[(E)-heptadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (E)-docos-13-enoate
[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] tricosanoate
[(2S)-3-hydroxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] henicosanoate
[(2S)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] docosanoate
[(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-hexadec-9-enoate
1-Eicosanoyl-3-(9Z,12Z-octadecadienoyl)-sn-glycerol
CmE(18:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(38:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
ChE(19:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl (9z,12z)-octadeca-9,12-dienoate
3-{[10-(2-hexylcyclopropyl)-2-hydroxydecanoyl]oxy}-n-(2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl)hexadecanimidic acid
9(11),12-ursadien-3β-ol 3-o-palmitate
{"Ingredient_id": "HBIN013960","Ingredient_name": "9(11),12-ursadien-3\u03b2-ol 3-o-palmitate","Alias": "NA","Ingredient_formula": "C46H78O2","Ingredient_Smile": "CCCCCCCCCCCCCCCC(=O)OC1CCC2(C(C1(C)C)CCC3(C2=CC=C4C3(CCC5(C4C(C(CC5)C)C)C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22245","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}